Vincent Primo

Vincent Primo is a Patent Agent at Clark+Elbing LLP, specializing in the drafting and prosecution of patent applications since February 2021. Previously, Vincent served as a Technology Specialist and Postdoctoral Fellow at Boston College, where work focused on optimizing ATAC-sequencing protocols and investigating genetic virulence factors in Toxoplasma gondii during a PhD candidacy. Early research experience includes roles as a Research Technician at Schepens Eye Research Institute, where a biomarker for CADASIL was discovered, and as a Research Intern at Harvard Catalyst, which involved asthma biomarker investigations. Educational credentials comprise a Doctor of Law (JD) degree from New England Law | Boston, a PhD in Molecular Biology from Boston College, and a Bachelor of Science in Biology from the University of Massachusetts Amherst.